These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7952)

  • 1. Efficacy of cardioselective beta adrenergic blockade with intravenously administered tolamolol in the treatment of cardiac arrhythmias.
    Amsterdam EA; Lee G; Morrison S; Tonkin MJ; DeMaria AN; Mason DT
    Am J Cardiol; 1976 Aug; 38(2):195-9. PubMed ID: 7952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.
    Gray RJ; Bateman TM; Czer LS; Conklin CM; Matloff JM
    J Am Coll Cardiol; 1985 Jun; 5(6):1451-6. PubMed ID: 2860148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia.
    Sung RJ; Blanski L; Kirshenbaum J; MacCosbe P; Turlapaty P; Laddu AR
    J Clin Pharmacol; 1986 Mar; 26(S1):A15-A26. PubMed ID: 2870082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of cardioselective beta-adrenergic blockade with intravenously administered metoprolol in the treatment of supraventricular tachyarrhythmias.
    Amsterdam EA; Kulcyski J; Ridgeway MG
    J Clin Pharmacol; 1991 Aug; 31(8):714-8. PubMed ID: 1880230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of supraventricular arrhythmias with a cardioselective beta-receptor blocker (tolamolol)].
    Pfisterer M; Halter J; Nager F
    Schweiz Med Wochenschr; 1976 Apr; 106(16):549-50. PubMed ID: 989952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of esmolol (ASL-8052: an ultrashort-acting beta-adrenergic blocking agent) for control of ventricular rate in supraventricular tachycardias.
    Byrd RC; Sung RJ; Marks J; Parmley WW
    J Am Coll Cardiol; 1984 Feb; 3(2 Pt 1):394-9. PubMed ID: 6141193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenergic blockade of the lung. Dose-dependent cardioselectivity of tolamolol in asthma.
    Fleming GM; Chester EH; Schwartz HJ; Jones PK
    Chest; 1978 Jun; 73(6):807-12. PubMed ID: 350512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic activity of esmolol (ASL-8052)--a novel ultra-short acting beta-adrenoreceptor blocking agent.
    Klein G; Wirtzfeld A; Alt E; Steck J; Saunders R; Hulse J; Kartzinel R; Lee R; Laddu AR
    Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):112-7. PubMed ID: 6142005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. The Esmolol vs Placebo Multicenter Study Group.
    Anderson S; Blanski L; Byrd RC; Das G; Engler R; Laddu A; Lee R; Rajfer S; Schroeder J; Steck JD
    Am Heart J; 1986 Jan; 111(1):42-8. PubMed ID: 2868645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias.
    Steinberg JS; Katz RJ; Somberg JC; Keefe D; Laddu AR; Burge J
    Am J Cardiol; 1986 Nov; 58(10):1005-8. PubMed ID: 2877563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina.
    Aronow WS; March H; Vangrow JS; Cassidy J; Kern JC; Khemka M; Vawter M; Pagano J
    Br Heart J; 1974 Nov; 36(11):1078-81. PubMed ID: 4155953
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of practolol in supraventricular arrhythmias associated with acute illnesses.
    Pribble AH; Conn RD
    Am J Cardiol; 1975 May; 35(5):645-50. PubMed ID: 1124718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esmolol: safety and efficacy in postoperative cardiothoracic patients with supraventricular tachyarrhythmias.
    Schwartz M; Michelson EL; Sawin HS; MacVaugh H
    Chest; 1988 Apr; 93(4):705-11. PubMed ID: 2894920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter.
    Platia EV; Michelson EL; Porterfield JK; Das G
    Am J Cardiol; 1989 Apr; 63(13):925-9. PubMed ID: 2564725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with intravenous metoprolol in supraventricular tachyarrhythmias. A multicentre study.
    Rehnqvist N
    Ann Clin Res; 1981; 13 Suppl 30():68-72. PubMed ID: 7027895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor blockade: electrophysiology and antiarrhythmic mechanisms.
    Sung RJ; Tai DY; Svinarich JT
    Am Heart J; 1984 Oct; 108(4 Pt 2):1115-20. PubMed ID: 6148871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tolamolol versus propranolol on systolic time intervals in angina.
    Aronow WS; Vawter M; Spivack N; Warren M; Laverty W
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1069-76. PubMed ID: 4154826
    [No Abstract]   [Full Text] [Related]  

  • 18. [1st experiences with the clinical use of a new beta-blocking agent (tolamolol) in some heart diseases].
    Neviani V; Tosi P; Prampolini ML
    Clin Ter; 1976 Jun; 77(5):451-8. PubMed ID: 12901
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.
    Jackson G; Atkinson L; Oram S
    Br Med J; 1975 Mar; 1(5960):708-12. PubMed ID: 804952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of a new beta-adrenoceptor blocking compound, tolamolol, on haemo-dynamics and myocardial function in man.
    Hillis WS; Hutton I; Lawrie TD; Lorimer AR; Reid JM
    Br J Pharmacol; 1974 May; 51(1):15-9. PubMed ID: 4155334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.